Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice

Sickle cell disease (SCD)–associated nephropathy is a major source of morbidity and mortality in patients because of the lack of efficacious treatments targeting renal manifestations of the disease. Here, we describe a long-term treatment strategy with the selective endothelin-A receptor (ET(A)) ant...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Am Soc Nephrol
Päätekijät: Kasztan, Malgorzata, Fox, Brandon M., Speed, Joshua S., De Miguel, Carmen, Gohar, Eman Y., Townes, Tim M., Kutlar, Abdullah, Pollock, Jennifer S., Pollock, David M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Nephrology 2017
Aiheet:
Basic Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5533228/
https://ncbi.nlm.nih.gov/pubmed/28348063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016070711
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia